Time-dependent expression of endothelin-1 in lungs and the effects of TNF-α blocking peptide on acute lung injury in an endotoxemic rat model

Biomedical Research

Volumn 32, Issue 1, 2011, Pages 9-17

  Jesmin, Subrina ^a,b   Yamaguchi, Naoto ^c   Zaedi, Sohel ^b,c   Sultana, Sayeeda Nusrat ^a,b   Iwashima, Yoshio ^a,b   Sawamura, Atsushi ^d   Gando, Satoshi ^d  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GAS PARAMETERS; CLINICAL FEATURE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE RESPONSE; DOWN REGULATION; DRY WEIGHT; ENDOTOXEMIA; LUNG STRUCTURE; LUNG WEIGHT; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEPSIS; SYSTOLIC BLOOD PRESSURE; TISSUE LEVEL; TISSUE STRUCTURE; WISTAR RAT;

ACUTE LUNG INJURY; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; ENDOTHELIN-1; ENDOTOXEMIA; LACTIC ACID; LIPOPOLYSACCHARIDES; LUNG; MALE; ORGAN SIZE; PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS; RATTUS NORVEGICUS;

EID: 79952805107     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.32.9     Document Type: Article

References (45)

1. Albertini M, Ciminaghi B, Mazzola S and Clement MG (2001) Improvement of respiratory function by bosentan during en-dotoxic shock in the pig. Prostaglandins Leukot Essent Fatty Acids 65, 103-108.
2. Battistini B, Forget MA and Laight D (1996) Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines. Shock 5, 167-183.
3. Beutler B and Cerami A (1989) The biology of cachectin/ TNF-a primary mediator of the host response. Annu Rev Immunol 7, 625-655.
4. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420, 885-891.
5. Corder R, Carrier M, Khan N, Klemm P and Vane JR (1995) Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells. J Cardiovasc Pharmacol 26, S56-58.
6. Costa EL, Schettino IA and Schettino GP (2006) The lung in sepsis: guilty or innocent? Endocr Metab Immune Disord Drug Targets 6, 213-216.
7. Coulombe M, Battistini B, Stankova J, Pouliot P and Bisson-nette EY (2002) Endothelins regulate mediator production of rat tissue-cultured mucosal mast cells. Up-regulation of Th1 and inhibition of Th2 cytokines. J Leukoc Biol 71, 829-836.
8. Filep JG, Sirois MG, Rousseau A, Fournier A and Sirois P (1991) Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br J Pharmacol 104, 797-804.
9. Fujii Y, Magder S, Cernacek P, Goldberg P, Guo Y and Hussain SN (2000) Endothelin receptor blockade attenuates lipopolysaccharide-induced pulmonary nitric oxide production. Am J Respir Crit Care Med 161, 982-989.
10. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD and Martin TR (1996) Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 154, 602-611.
11. Helset E, Sildnes T and Konopski S (1994) Endothelin-1 stimulates monocytes in vitro to release chemotactic activity identified as interleukin-8 and monocyte chemotactic protein-1. Mediators Inflamm 3, 155-160.
12. Helset E, Sildnes T, Seljelid R and Konopski S (1993) Endo-thelin-1 stimulates human monocytes in vitro to release TNF-1α, IL-1β and IL-6. Mediators Inflamm 2, 417-422.
13. Henry PJ, Rigby PJ, Self GJ, Preuss JM and Goldie RG (1990) Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle. Br J Pharmacol 100, 786-792.
14. Horgan MJ, Pinheiro JM and Malik AB (1991) Mechanism of endothelin-1-induced pulmonary vasoconstriction. Circ Res 69, 157-164.
15. Ishizaki T, Shigemori K, Nakai T, Miyabo S, Hayakawa M, Ozawa T, Voelkel NF and Chang SW (1995) Endothelin-1 potentiates leukotoxin-induced edematous lung injury. J Appl Physiol 79, 1106-1111.
16. Jesmin S, Gando S, Matsuda N, Sakuma I, Kobayashi S, Sakuraya F and Hattori Y (2004) Temporal changes in pulmonary expression of key procoagulant molecules in rabbits with endotoxin-induced acute lung injury: elevated expression levels of protease-activated receptors. Thromb Haemost 92, 966-979.
17. Jesmin S, Gando S, Zaedi S and Sakuraya F (2006) Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis. Thromb Haemost 96, 830-838.
18. Jesmin S, Gando S, Zaedi S and Sakuraya F (2007) Differential expression, time course and distribution of four PARs in rats with endotoxin-induced acute lung injury. Inflamma-tion 30, 14-27.
19. Kuklin VN, Kirov MY, Evgenov OV, Sovershaev MA, Sjöberg J, Kirova SS and Bjertnaes LJ (2004) Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep. Crit Care Med 32, 766-773.
20. Marsden PA and Brenner BM (1992) Transcriptional regulation of the endothelin-1 gene by TNF-α. Am J Physiol Cell Physiol 262, C854-C861.
21. Mathison JC, Wolfson E and Ulevitch RJ (1988) Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 81, 1925-1237.
22. McKay KO, Black JL, Diment LM and Armour CL (1991) Functional and autoradiographic studies of endothelin-1 and endothelin-2 in human bronchi, pulmonary arteries, and airway parasympathetic ganglia. J Cardiovasc Pharmacol 17, S206-209.
23. McMillen MA and Sumpio. (1995) BE Endothelins: polyfunctional cytokines. J Am Coll Surg 180, 621-637.
24. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F and Postlethwaite A (1995) Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 108, 1303-1314.
25. Mitaka C, Hirata Y, Nagura T, Tsunoda Y and Amaha K (1993) Circulating endothelin-1 concentrations in acute respiratory failure. Chest 104, 476-480.
26. Miyauchi T and Masaki T (1999) Pathophysiology of endo-thelin in the cardiovascular system. Annu Rev Physiol 61, 391-415.
27. Morrison DC and Ryan JL (1979) Bacterial endotoxins and host immune responses. Adv Immunol 28, 293-450.
28. Morrison DC and Ryan JL (1987) Endotoxins and disease mechanisms. Annu Rev Med 38, 417-432.
29. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H and Takatsuki K (1997) Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol Lung Cell Mol Physiol 272, L197-L202.
30. Norman JG, Fink GW and Franz MG (1995) Acute pancre- atitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 130, 966-970.
31. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F 2nd, Park DR, Pugin J, Skerrett SJ, Hudson LD and Martin TR (2001) Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 164, 1896-1903.
32. Peralta C, Bulbena O, Bargalló R, Prats N, Gelpí E and Roselló-Catafau J (2000) Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation 70, 1761-1770.
33. Pittet JF, Morel DR, Hemsen A, Gunning K, Lacroix S, Suter M and Lungerg JM (1991) Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 213, 261-264.
34. Putensen C and Wrigge H (2000) Ventilator-associated systemic inflammation in acute lung injury. Intensive Care Med 26, 1411-1413.
35. Remick DG, Kunkel RG, Larrick JW and Kunkel SL (1987) Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest 56, 583-590.
36. Ryszard J. Gryglewski, Pawel PW, Uracz W, Janowska E, Joanna BB, Balbatun O, Patton S, Brovkovych V and Malinski T (1998) Protective role of pulmonary nitric oxide in the acute phase of endotoxemia in rats. Circ Res 82, 819-27.
37. Sheridan BC, McIntyre RC Jr, Meldrum DR and Fullerton DA (1998) L-arginine prevents lung neutrophil accumulation and preserves pulmonary endothelial function after endotox-in. Am J Physiol 274, L337-L342.
38. Simpson SQ and Casey LC (1989) Role of tumor necrosis factor in sepsis and acute lung injury. Crit Care Clin 5, 27- 47.
39. Sugiura M, Inagami T and Kon V (1989) Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 161, 1220-1227.
40. Takahashi K, Silva A, Cohen J, Lam HC, Ghatei MA and Bloom SR (1990) Endothelin immunoreactivity in mice with gram-negative bacteraemia: relationship to tumor necrosis factor-α. Clin Sci (Lond) 79, 619-623.
41. Wanecek M, Oldner A, Rudehill A, Sollevi A, Alving K and Weitzberg E (1997) Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan. Shock 7, 364-370.
42. Weitzberg E, Lundberg JM and Rudehill A (1991) Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 33, 222-227.
43. Yamaguchi N, Jesmin S, Zaedi S, Shimojo N, Maeda S, Gando S, Koyama A and Miyauchi T (2006) Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat. Peptides 27, 2258-2270.
44. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K and Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothe-lial cells. Nature 332, 411-415.
45. Zaedi S, Jesmin S, Maeda S, Shimojo N, Yamaguchi I, Goto K and Miyauchi T (2006) Alterations in gene expressions encoding preproET-1 and NOS in pulmonary tissue in endotox-emic rats. Exp Biol Med (Maywood) 231, 992-996.